Moderna, Inc.
CH ˙ SWX ˙ US60770K1079
SecurityCH:MRNA / Moderna, Inc.
InstitutionIntrinsic Value Partners, LLC
Latest Disclosed Ownership8,914 shares
Latest Disclosed Value $ 452,831
Intrinsic Value Partners, LLC reports 32.18% decrease in ownership of MRNA / Moderna, Inc.

On April 28, 2026 - Intrinsic Value Partners, LLC filed a 13F-HR form disclosing ownership of 8,914 shares of Moderna, Inc. (CH:MRNA) valued at $452,831 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 13,144 shares of Moderna, Inc.. This represents a change in shares of -32.18% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F Moderna COM 60770K107 8,914 -4,230 -32.18 453 16.80 0.3489
2026-01-21 2025-12-31 13F Moderna COM 60770K107 13,144 -6,404 -32.76 388 -23.21 0.2907
2025-11-14 2025-09-30 13F Moderna COM 60770K107 19,548 -9,243 -32.10 505 -36.52 0.4089
2025-07-21 2025-06-30 13F Moderna COM 60770K107 28,791 -7,420 -20.49 794 -22.61 0.7067
2025-05-08 2025-03-31 13F Moderna COM 60770K107 36,211 -44 -0.12 1,027 -31.92 1.0133
2025-01-30 2024-12-31 13F Moderna COM 60770K107 36,255 -15,137 -29.45 1,507 -56.12 1.5142
2024-11-04 2024-09-30 13F Moderna COM 60770K107 51,392 24,505 91.14 3,435 7.58 3.4374
2024-07-25 2024-06-30 13F Moderna COM 60770K107 26,887 -25 -0.09 3,193 11.34 3.3290
2024-04-22 2024-03-31 13F Moderna COM 60770K107 26,912 -459 -1.68 2,868 5.33 3.0562
2024-02-07 2023-12-31 13F Moderna COM 60770K107 27,371 6,760 32.80 2,722 27.91 3.1745
2023-10-17 2023-09-30 13F Moderna COM 60770K107 20,611 5,600 37.31 2,129 16.73 2.7367
2023-08-02 2023-06-30 13F Moderna COM 60770K107 15,011 3,051 25.51 1,824 -0.71 2.2999
2023-04-18 2023-03-31 13F Moderna COM 60770K107 11,960 -560 -4.47 1,837 91,700.00 2.4840
2023-01-12 2022-12-31 13F Moderna COM 60770K107 12,520 -1,330 -9.60 2 -99.88 3.0790
2022-10-14 2022-09-30 13F Moderna COM 60770K107 13,850 3,715 36.66 1,638 13.12 2.2761
2022-07-18 2022-06-30 13F Moderna COM 60770K107 10,135 10,135 1,448 1.8474
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.